Portrait of Jill N. Burke, CNP, DipACLM

Jill N. Burke,

CNP, DipACLM

Jill N. Burke,

CNP, DipACLM

Nurse Practitioner, Massachusetts General Hospital

Portrait of Jill N. Burke, CNP, DipACLM

Jill N. Burke,

CNP, DipACLM

Nurse Practitioner, Massachusetts General Hospital

Jill Burke has spent the last 35 years at Massachusetts General Hospital, with the first 12 years as inpatient hematology/oncology staff nurse, and the last 23 years at a nurse practitioner. Jill’s focus of care has been multiple myeloma for 15 years. She presently works in the outpatient setting, managing patients with plasma cell diseases throughout diagnosis and treatment.

She is a strong patient advocate, ensuring that patients reach their optimal level of functioning and enjoy life. She is known for explaining to newly diagnosed patients that she hopes their diagnosis will occupy a small sliver in the pie of their life. Jill is certified by the American College of Lifestyle Medicine as a lifestyle coach, and she is in the process of organizing lifestyle medicine clinics for patients diagnosed with monoclonal gammopathy of unknown significance, multiple myeloma, and post CAR-T. Jill has given talks and presented posters both nationally and internationally.

Jill's Shared Resources

Frailty Assessments in Personalized Treatment for Older Adults with Multiple Myeloma: A Case Study

Authors of this article discuss the role of frailty assessments in managing older adults with multiple myeloma (MM). Frailty scores, including the IMWG score, are valuable tools for predicting treatment...
CURATED BY:
Jill N. Burke,
CNP, DipACLM

Advances in MRD Testing for Multiple Myeloma: Impact on Prognosis and Treatment Decisions

This article reviews the role of minimal residual disease (MRD) testing in multiple myeloma (MM), highlighting its association with improved progression-free survival and overall survival. MRD-negative status correlates with better...
CURATED BY:
Jill N. Burke,
CNP, DipACLM

Advances in Diagnosing and Treating High-Risk Multiple Myeloma

High-risk multiple myeloma (MM) is a challenging condition to diagnose and treat, requiring effective tools to identify patients and deliver targeted therapies....
CURATED BY:
Jill N. Burke,
CNP, DipACLM

Provided by an unrestricted grant from

Provided by an unrestricted grant from

Share